PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Vistagen Therapeutics, Inc.
Filed: September 2, 2011
Period of Report: September 2, 2011
Accession Number: 0001415889-11-000925

View Document ↗ View on SEC.gov ↗